Definitive Healthcare Corp. DH
1.17 USD +0.04 (+3.54%)
At closeNov 3, 2026, 4:00 PM EST
1.17 0.00 0.00%
After hours · Nov 3, 4:00 PM ET
1.13 Day range 1.21
0.61 52-week range 3.00
- YTD
- -59.23%
- 1 year
- -59.09%
Analyst view
Consensus: buy
Buy
Price target (mean) 5.25 +348.7% upside
Now 1.17
- Target (low)
- 4.00
- Target (mean)
- 5.25
- Target (high)
- 7.00
Ratings (0m) 14 4 buy · 9 hold · 1 sell
- Strong buy0
- Buy4
- Hold9
- Sell0
- Strong sell1
Recommendation trend
- This month 14
- 1 month ago 13
- 2 months ago 13
- 3 months ago 14
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.0718 | 0.07 – 0.08 | 0.07 | +2.6% | 60.59M | -8.1% | 13 |
| Next quarter | 0.07333 | 0.06 – 0.09 | 0.08 | -8.3% | 59.95M | -5.5% | 9 |
| Current year | 0.34382 | 0.34 – 0.36 | 0.30 | +14.6% | 250.45M | -0.4% | 13 |
| Next year | 0.29464 | 0.22034 – 0.37 | 0.34382 | -14.3% | 241.19M | -3.7% | 13 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 20, 2024 | Stephens & Co. | Initiated | — | Equal-Weight |
| Nov 8, 2024 | Needham | Reiterated | — | Hold |
| Sep 17, 2024 | BTIG | Initiated | — | Buy |
| Aug 9, 2024 | Deutsche Bank | Maintained | Hold | Hold |
| Aug 7, 2024 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Aug 7, 2024 | Baird | Maintained | Neutral | Neutral |
| Aug 6, 2024 | Morgan Stanley | Maintained | Equal-Weight | Equal-Weight |
| Aug 6, 2024 | Needham | Reiterated | — | Hold |
| Jul 31, 2024 | Stifel | Maintained | Buy | Buy |
| Jul 31, 2024 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Jul 31, 2024 | Baird | Maintained | Neutral | Neutral |
| Jul 31, 2024 | JP Morgan | Downgrade | Neutral | Underweight |
| Jul 31, 2024 | Needham | Reiterated | — | Hold |
| May 9, 2024 | Deutsche Bank | Maintained | Hold | Hold |
| May 9, 2024 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| May 8, 2024 | Canaccord Genuity | Maintained | Hold | Hold |
| May 8, 2024 | Stifel | Maintained | Buy | Buy |
| May 8, 2024 | Needham | Reiterated | — | Hold |
| May 8, 2024 | Morgan Stanley | Downgrade | Overweight | Equal-Weight |
| Mar 1, 2024 | Barclays | Maintained | Equal-Weight | Equal-Weight |
| Feb 29, 2024 | Canaccord Genuity | Maintained | Hold | Hold |
| Jan 17, 2024 | Stifel | Maintained | Buy | Buy |
| Jan 17, 2024 | Needham | Downgrade | Buy | Hold |
| Jan 5, 2024 | Canaccord Genuity | Downgrade | Buy | Hold |
| Nov 3, 2023 | Morgan Stanley | Maintained | Overweight | Overweight |
| Aug 16, 2023 | Goldman Sachs | Maintained | Neutral | Neutral |
| Aug 15, 2023 | Canaccord Genuity | Maintained | Buy | Buy |
| Aug 15, 2023 | Morgan Stanley | Maintained | Overweight | Overweight |
| Aug 15, 2023 | B of A Securities | Maintained | Neutral | Neutral |
| Aug 15, 2023 | Needham | Reiterated | Buy | Buy |
